4Life’s Transfer Factor Max was awarded Nutraceutical Innovation of the Year by the BioTech Breakthrough program, an event designed to recognize the world’s innovative Life Sciences & Biotechnology advancements.
Judges for the award conducted comprehensive evaluations of companies that are redefining research, development, manufacturing and delivery methods to highlight the innovations they believe are shaping the future of health and wellness.
“We are honored to receive Nutraceutical Innovation of the Year from BioTech Breakthrough,” said Danny Lee, 4Life President and CEO. “This award is a testament to 4Life founder David Lisonbee’s commitment to scientific research. It also showcases the significance of our discovery of plant-based transfer factor peptides and highlights 4Life’s ongoing goal of developing the best immune system nutraceuticals anywhere—period.”
